Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 5 February 2002
Vol. 2002, Issue 118, p. tw59
[DOI: 10.1126/stke.2002.118.tw59]


Insulin Signaling Inhibited by Ganglioside

Tumor necrosis factor α (TNF-α) inhibits insulin signaling and, in vivo, is believed to be one mechanism underlying insulin resistance in type II diabetes. Tagami et al. show that TNF signaling promotes the synthesis by increasing the expression of the GM3 synthase, leading to increased amounts of the ganglioside GM3 at the plasma membrane of 3T3-L1 adipocytes. TNF-α also inhibited insulin receptor-mediated phosphorylation of the insulin receptor substrate 1 (IRS-1). This effect could be mimicked by application of exogenous GM3 and blocked by treatment of the cells with an inhibitor of the biosynthesis of glycosphingolipids. The GM3 synthase transcript was expressed at higher levels in fat from obese mice (ob/ob and Zucker strains) than from lean fat tissue from control animals, further supporting a role for GM3 in insulin-resistance phenotypes. Thus, changes in the lipid composition of the membrane appear to be one mechanism underlying TNF-α-mediated inhibition of insulin signaling, which may lead to insulin resistance and obesity in vivo.

S. Tagami, J.-i. Inokuchi, K. Kabayama, H. Yoshimura, F. Kitamura, S. Uemura, C. Ogawa, A. Ishii, M. Saito, Y. Ohtuska, S. Sakaue, Y. Igarashi, Ganglioside GM3 participates in the pathological conditions of insulin resistance. J. Biol. Chem. 277, 3085-3092 (2002). [Abstract] [Full Text]

Citation: Inhibited by Ganglioside. Sci. STKE 2002, tw59 (2002).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882